NEW YORK – AstraZeneca and Daiichi Sankyo on Wednesday said they have begun three new Phase III trials to test the activity of the Trop2-targeted antibody-drug conjugate datopotamab deruxtecan ...

You don't need a subscription to stream your favorite songs. With these tested and recommended streaming music services, you can enjoy sweet tunes without spending a dime. My career has taken me ...

A health ministry panel of experts on July 31 endorsed the plan for Daiichi Sankyo Co. to begin producing and distributing the vaccine, which creates immunity for the conventional strain of the virus.

It gives people more time before their cancer gets worse. The drug companies that make it, AstraZeneca and Daiichi Sankyo, say some patients are still alive after three years. There's no dispute ...